Martin Elise, Morgan Daniel J, Pryor Rachel, Bearman Gonzalo
Department of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Antimicrob Steward Healthc Epidemiol. 2024 Sep 20;4(1):e137. doi: 10.1017/ash.2024.350. eCollection 2024.
Contact precautions for methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant (VRE) have limited data on efficacy and have been associated with patient harm. Still, a 2015 (SHEA) Research Network (SRN) survey showed only 7% of hospitals discontinued routine MRSA/VRE contact precautions. The study objectives were to identify the current proportion of hospitals that have discontinued routine MRSA/VRE contact precautions and motivations for change.
An online survey was conducted of the SRN on current use and views of contact precautions for MRSA/VRE in each facility. An initial survey followed by 2 reminders was sent between 5/18/2021 and 6/9/2021.
SRN facilities.
The response rate was 43% (37/87) of facilities surveyed and 35% of respondents were not routinely using contact precautions for MRSA and VRE. The most frequently reported reason for discontinuing contact precautions was research on the safety of discontinuing contact precautions without an increase in healthcare-associated infections (reported for 92% of facilities for MRSA and 100% for VRE). Of those using contact precautions, the most frequently reported reason to continue was a lack of safety data for discontinuation (MRSA 58% and VRE 46%). Most of those continuing contact precautions were interested in using contact precautions differently in their facility (MRSA 63% and VRE 58%).
Over one in three healthcare facilities surveyed do not use contact precautions for MRSA or VRE. Most facilities choosing to continue contact precautions are interested in a different implementation strategy.
针对耐甲氧西林金黄色葡萄球菌（MRSA）和耐万古霉素肠球菌（VRE）的接触预防措施在疗效方面的数据有限，且已被证明与患者伤害有关。尽管如此，2015年医疗保健流行病学学会（SHEA）研究网络（SRN）的一项调查显示，只有7%的医院停止了常规的MRSA/VRE接触预防措施。本研究的目的是确定目前已停止常规MRSA/VRE接触预防措施的医院比例以及改变的动机。
对SRN进行了一项在线调查，内容涉及各机构对MRSA/VRE接触预防措施的当前使用情况和看法。在2021年5月18日至2021年6月9日期间发送了初始调查问卷，并随后进行了2次提醒。
SRN机构。
参与调查的机构回复率为43%（37/87），35%的受访者未对MRSA和VRE常规采取接触预防措施。停止接触预防措施最常报告的原因是关于在不增加医疗相关感染的情况下停止接触预防措施安全性的研究（92%的机构报告了针对MRSA的情况，100%报告了针对VRE的情况）。在采取接触预防措施的机构中，最常报告的继续采取该措施的原因是缺乏停止措施的安全性数据（MRSA为58%，VRE为46%）。大多数继续采取接触预防措施的机构有兴趣在其机构中采用不同的接触预防措施实施方式（MRSA为63%，VRE为58%）。
超过三分之一接受调查的医疗机构未对MRSA或VRE采取接触预防措施。大多数选择继续采取接触预防措施的机构对不同的实施策略感兴趣。
